Introduction

Hyperlactatemia in critically ill patients, and particularly those in shock, is usually interpreted as a marker of oxygen debt and global tissue hypoxia, and as a witness of anaerobic metabolism [13]. The notion that high lactate levels reflect tissue hypoxia has been questioned in light of data that suggest increased lactate production may occur as a result of aerobic glycolysis stimulated by beta-2-adrenergic receptor ligation [4, 5]. Indeed, several human and animal studies have demonstrated that epinephrine, via β2 stimulation, increases cyclic adenosine monophosphate production, thereby inducing stimulation of glycogenolysis and glycolysis leading to ATP production and activation of the Na+K+-ATPase pump [6, 7]. This activation consumes ATP, thereby leading to the generation of ADP. This ADP, via phosphofructokinase stimulation, reactivates glycolysis and hence generates more pyruvate and, consequently, more lactate. Muscle tissue, which represents approximately 40% of total body cell mass, is particularly involved in this process [8]. We recently demonstrated that, in human septic shock, muscle was a net producer of lactate and that this production could be totally inhibited by ouabain, thus confirming a Na+K+-ATPase-dependent mechanism that appears to be independent of tissue hypoxia [7, 9]. We also recently demonstrated in rat models of hemorrhagic and septic shock that muscle lactate production during shock states is related, at least partially, to increased Na+K+-ATPase activity under β2 stimulation [10].

Catecholamine secretion, especially epinephrine, is a component of the early systemic response to acute physiologic insult. Epinephrine levels increase after cardiac and non-cardiac surgery, brain injury, trauma, myocardial infarction and septic shock [11]. Indeed, the initial reaction to a severe insult, regardless of etiology, is catecholamine secretion. It therefore appears logical that patients with severe sepsis have increased epinephrine levels with a subsequent increase in muscle lactate and pyruvate levels. An increased plasma lactate level is part of the definition of severe sepsis but is not always present, depending on the rate of production compared to the rate of elimination.

The aim of this study was (1) to assess whether patients with sepsis without increased serum lactate levels have an increased muscle lactate and pyruvate production and its relationship with epinephrine levels, and (2) to demonstrate a link between this muscle lactate and pyruvate production, epinephrine concentration and the risk of developing septic shock within the first 48 h after ICU admission.

Methods

Study population

This study was approved by the institutional review board, and patients or their relatives provided written informed consent before enrollment.

To be included in the study, patients had to fulfill the following requirements: (1) a state of sepsis defined according to the ACCP/SCCM consensus criteria [12], (2) a mean arterial pressure (MAP) above or equal to 65 mmHg without vasopressor therapy and (3) a normal plasma lactate concentration (<2.2 mmol/l). All patients were monitored with an arterial catheter (radial or femoral site). Patients previously treated with beta blockers were not included.

A control group of ten hemodynamically stable ICU patients without infection was also studied.

Intervention

The treatment of sepsis was conducted according to international recommendations [13, 14]. Adequate volume resuscitation was assumed to have been achieved when respiratory variations in pulse pressure (in supine patients without spontaneous respiratory efforts) were less than 13% or when additional fluid administration did not yield further increases in the cardiac index (CI). After optimal volume resuscitation and in case of persistent hypotension, we used the lowest effective dose of norepinephrine to maintain MAP between 65 and 70 mmHg. Cardiac index was estimated as per the decision of the physician in charge by echocardiography or PiCCO (PiCCO, Pulsion Medical Systems, Munich, Germany) monitoring combined with intermittent or continuous central venous oxygen saturation (ScvO2) measurement through the venous central catheter placed with the tip in the superior vena cava. Patients were sedated with the lowest effective dose of remifentanyl [50–100 µg/h combined when necessary with a low dose of midazolam (1–5 mg/h].

Microdialysis technique

A microdialysis catheter (CMA 60, CMA/Microdialysis, Stockholm, Sweden) was inserted on admission into the quadriceps femoris muscle. The probe was connected to a microinjection pump that was continuously infused with lactate-free Ringer’s solution. The length of the microdialysis membrane (30 mm) together with a very slow perfusion flow rate of 0.3 μl/min guarantees 100 percent recovery (i.e., uptake of molecules from the interstitial space) for molecules up to 20 kDa, thus providing true tissue concentrations. A 1-h equilibration period was allowed following insertion of the probe, after which measurements were performed every 6 h for 24 h.

Measurements

Lactate, pyruvate and glucose concentrations were measured every 6 h in the dialysate fluid using a CMA 600 analyser (Microdialysis AB, Solna, Sweden) as well as in arterial blood.

For lactate, arterial blood samples were collected in fluoride-oxalate-containing tubes. Lactate was measured by an enzymatic colorimetric method adapted to the Wako automatic analyzer (Biochem Systems, Paris, France). Normal blood values are <2.2 mmol/l.

For pyruvate, arterial blood samples were immediately deproteinized by addition of iced perchloric acid (1 mol/l) and analyzed. Pyruvate was measured by the enzymatic UV method. The normal range of values in blood is 40–68 μmol/l.

Plasma epinephrine concentration was measured using a HPLC electrochemical detection technique and UV detection (Primesep 200, SIELC Technologies, Prospect Heights, IL). Normal blood values are <0.55 nmol/l.

Statistical analysis

Normally distributed (Kolmogorov-Smirnov test) quantitative variables were analyzed by the Student’s t test and results expressed as mean ± SD. Non-normally distributed variables were studied with the non-parametric Mann-Whitney U test and results expressed as median (IQR). The change in measurements over time was calculated for the microdialysis catheter as well as for blood and analyzed using the repeated measures ANOVA test. To determine the sensitivity and specificity of the lactate gradient and epinephrine concentration in predicting septic shock, a ROC curve was constructed. Analysis was completed with the Prism 4.0c software (Graphpad Software, Inc.), and a two-tailed P value of less than 0.05 was considered to indicate statistical significance.

Results

Forty consecutive patients were included with a mean age of 67 ± 12 years. The characteristics of the study groups are shown in Table 1. An infectious microorganism was documented in 36/40 patients.

Table 1 Baseline characteristics

Control group

The ICU control group included ten hemodynamically stable patients without sepsis admitted for intracerebral haemorrhage. The mean age was 63 ± 5 years. The lactate level was 0.90 ± 0.2 mmol/l, the blood pyruvate level was 0.100 ± 0.04 mmol/l, and the lactate/pyruvate ratio was 8.4 ± 1.5. There was no gradient between muscle and arterial levels for lactate and pyruvate in the control group. The epinephrine level was slightly elevated when compared to our reference values (1.3 ± 0.1 nmol/l vs. 0.55 nmol/l; P = 0.02).

Sepsis group

The lactate level was 1.5 ± 0.3 mmol/l, the blood pyruvate level was 0.200 ± 0.05 mmol/l, and the lactate/pyruvate ratio was 7.5 ± 1.4. Muscle lactate concentrations were always higher than arterial lactate levels during the study period with a mean positive gradient of 1.58 ± 0.2 mmol/l (P = 0.001) (Fig. 1 and Figure 1 online supplement). Similarly, the muscle pyruvate concentration was always higher than the arterial pyruvate levels during the study period with a mean positive gradient of 370 ± 30 μmol/l (P = 0.03) (Figure 2, online supplement). At T0, there was a strong correlation between the lactate gradient and epinephrine concentration (r 2 = 0.7084, P < 0.0001) (Fig. 2).

Fig. 1
figure 1

Evolution of lactate gradient (muscle lactate-arterial lactate) during the first 24 h. Open squares sepsis group (septic patients who did not develop septic shock; filled squares septic shock group (septic patients who developed septic shock). Numerical values indicate the number of patients in septic shock at the time of measurement. Values are expressed as mean ± SD

Fig. 2
figure 2

Linear regression analysis depicting the correlation between epinephrine concentration and lactate gradient on admission

Plasma glucose was elevated in all septic patients (8.2 ± 0.80 mmol/l). Epinephrine concentrations were also elevated when compared to reference values but also compared to the control population (3.4 ± 0.4 nmol/l vs. 0.55 nmol/l vs. 1.3 ± 0.1 nmol/l, respectively) (P = 0.01) (Fig. 3).

Fig. 3
figure 3

Epinephrine concentrations on admission and after 24 h in the sepsis group (septic patients who did not develop septic shock) and the septic shock group (septic patients who developed septic shock). Values are expressed as mean ± SD

Fifteen out of 40 patients further developed septic shock within 48 h after severe sepsis diagnosis. The only difference between these patients and patients who did not develop septic shock was significantly higher levels of the musculo-arterial gradient for both lactate (2.9 ± 0.3 vs. 0.7 ± 0.2) (Fig. 1 and Figure 1 online supplement) and pyruvate (740 ± 60 vs. 200 ± 20 μmol/l) (Figure 2 online supplement) and higher levels of epinephrine concentrations (6.2 ± 0.7 nmol/l vs. 2.5 ± 0.24 nmol/l) (Fig. 4). Moreover, these patients exhibited slightly increased lactate and pyruvate musculo-arterial gradients during the first 24 h (Fig. 1 and Figure 2 online supplement). Conversely, patients who did not develop septic shock normalized their gradients after 24 h (P = 0.004) (Fig. 1 and Figure 2 online supplement). Glucose concentrations did not differ between the two groups. The correlation between epinephrine concentration and lactate gradient was performed by means of a linear regression test.

Fig. 4
figure 4

ROC curve for lactate gradient (muscle lactate-arterial lactate) on admission for predicting evolution towards septic shock

To determine the optimal cutoff value of the musculo-arterial lactate gradient and epinephrine concentration on admission in predicting the evolution to septic shock, a ROC curve was constructed (Figure 3 online supplement and Figs. 4, 5). The area under the curve was, respectively, 0.96 ± 0.03 (95% CI, 0.90–1.02, P < 0.0001) and 0.94 ± 0.05 (95% CI, 0.83–1.052, P < 0.0001). At a value of 1.5 mmol/l, the musculo-arterial lactate gradient predicted the evolution to septic shock with a sensitivity of 100% (95% CI, 78–100%) and a specificity of 92% (95% CI, 74–99%). The positive likelihood ratio was 12.5. Conversely, at a value equal or superior to 5.2 nmol/l, the epinephrine concentration predicted the evolution to septic shock with a sensitivity of 93% (95% CI, 68–99%) and a specificity of 100% (95% CI, 86–100%). The positive likelihood ratio was 25.

Fig. 5
figure 5

ROC curve for epinephrine concentration on admission for predicting evolution towards septic shock

Discussion

This study demonstrates that patients with sepsis but without shock have increased epinephrine concentrations associated with muscle production of lactate and pyruvate despite normal plasma values. Moreover, patients who subsequently developed septic shock exhibited higher levels of both epinephrine and muscle lactate and pyruvate concentrations on admission.

Muscle produces lactate during sepsis

The microdialysis technique involves the insertion in a given tissue (brain, muscle, adipose tissue) of a semi-permeable membrane continuously infused with dialysis solution. At the tissue level, the solutes present in the interstitium freely diffuse into the catheter according to their concentration gradient. At a very low perfusion flow rate (0.3 μl/min) such as that used in this study, the gradient between muscle interstitium and arterial blood concentration indicates whether muscle produces or utilizes a specific substrate [15].

In the present study, lactate and pyruvate levels were always higher in muscle than in blood. This contrasts sharply to the findings observed in volunteers where the gradient between muscle and arterial blood was very low. This argues strongly in favor of muscle lactate production during severe sepsis [16]. As skeletal muscles account for approximately 40 percent of the total body-cell mass, this tissue may represent a major source of lactate during sepsis. On the other hand, despite a marked increase in lactate production, our patients did not have hyperlactatemia. The blood level of lactate reflects a balance between the production and metabolism of lactate by various tissues. In general, this concentration is less than 2 mmol/l, although daily production of lactate is actually 1,500 mmol/l [8]. Generated lactate can be transformed into oxaloacetate or alanine via the pyruvate pathway or can be utilized directly by periportal hepatocytes (60%) to produce glycogen and glucose (neoglycogenesis and neoglucogenesis; Cori cycle). The kidney also participates in the metabolism of lactate (30%), with the cortex classically acting as a metabolizer by neoglucogenesis and the medulla as a producer of lactate [8]. Since the blood lactate level reflects a balance between production and clearance, for any given mechanism that leads to increased lactate production, the blood level of lactate can be either elevated or normal, depending on the rates of lactate clearance. In this study, in the absence of tissue hypoxia and with normal liver and kidney function, it is likely that the increased rate of lactate production was compensated by an increase in lactate clearance.

Muscle lactate production is correlated with epinephrine concentration

According to previous experimental and clinical studies, it is likely that excess muscle lactate production during severe sepsis is linked to the higher levels of circulating epinephrine that we observed. Indeed, in the present study, we observed a strong correlation (r 2 = 0.7084) between epinephrine concentration and muscle-arterial blood lactate gradient. Moreover, we previously demonstrated the link between increased epinephrine levels and lactate muscle production in a rat study [10]. Epinephrine, which is one of the main stress mediators, acts on alpha, beta 1 as well as beta 2 adrenoreceptors [17]. The latter are considered to be responsible for the metabolic actions of epinephrine including hyperglycemia, hyperlactatemia and hypokalemia [18]. Epinephrine is associated with an increase in lactate concentration not only in patients with sepsis, but also in healthy volunteers at rest and during exercise. In the present study, our patients did not have any signs of hypoxia since they were normotensive, normolactatemic and had a normal lactate/pyruvate ratio, hence arguing for a non-hypoxic mechanism to explain muscle lactate formation.

Accelerated aerobic glycolysis during sepsis without shock

The basis for aerobic lactate muscle production during sepsis without shock is not straightforward. Accelerated aerobic glycolysis, a definite state when the rate of glucose metabolism exceeds the oxidative capacity of the mitochondria, is present during states associated with an increase in endogenous or exogenous catecholamines [19]. During sepsis, epinephrine-induced muscle lactate production may serve as the main metabolic precursor for the liver via the Cori cycle to produce glucose that may be used by glucose-dependent organs [20].

Muscle lactate production and plasma epinephrine concentrations are predictive of septic shock

Of further interest is the fact that the persistence and even the accentuation of the initial stress responses characterized by a persistent increase in epinephrine concentration is an early marker of severity despite the absence of systemic hemodynamic disorders. Muscle microdialysis is an invasive, expensive and difficult technique, and its use as a monitoring tool during sepsis is difficult for consideration in a routine manner. Nevertheless, the concept of a muscle lactate gradient as a predictor of septic shock is new. More useful for clinical practice is the fact that plasma epinephrine is also linked to patient prognosis. We are currently investigating the value of combined indirect signs of elevated epinephrine concentration, such as hyperglycemia, hypokaliemia and tachycardia, in predicting prognosis in sepsis.

Conclusions

Muscle lactate production (1) is present in severe sepsis despite the absence of systemic hyperlactatemia, (2) is correlated with the intensity of stress-induced epinephrine secretion and (3) is an early marker of septic shock.